Dubai, UAE: The Dubai Health Authority (DHA) launched Bushra an all-in-one IT solution for reproductive medicine during Arab Health 2020.

The DHA is displaying its latest innovations and smart solutions during Arab Health 2020, which is taking place from January 27 – 30 at the Dubai World Trade Centre.

His Excellency Humaid Al Qutami, Director General of the DHA launched the service, which provides clinicians, clinical scientists and other experts in fertility centers with perfect quality assurance and documentation of therapies.

By launching the service, patients and visitors to the center will be able to obtain data and information about their IVF treatment in a safe and confidential manner.

Bushra enables the collection of all data relevant to diagnostics and therapy such as findings, diagnoses, treatment process, treatment results and documented correspondence, so that they can be retrieved paperlessly from anywhere and anytime.

Commenting on the launch, His Excellency Humaid Al Qutami commended the role of the Dubai Fertility Center in giving hope to married couples who dream of having a family by providing quality services that treat all forms of infertility.

Al Qutami added that the Dubai Fertility Center has become locally and internationally renowned due to its experienced specialists and state-of-the-art equipment.

Hana Tahtawa, the Director of the Dubai Fertility Center explained that Bushra allows immediate access to all patient files to allow the organization of administrative tasks and processes intelligently.

“This includes a perfect cryo-management system including consistent documentation of information and sensitive data as well as a quick and uncomplicated execution of communication tasks such as medical reports, diagnostic reports etc... this will help expedite the registration of appointments and manage waiting lists more efficiently,” she concluded.

Arab Health visitors are welcome to visit the authority’s stand to learn about the latest health services adopted by the DHA.

-Ends-

For further information, please contact:
Kamakshi Gupta and Noor Nazzal
Communications Analysts- Media Dept.
Dubai Health Authority
klgupta@dha.gov.ae  nnnazzal@dha.gov.ae
+9714 2197455

About the Dubai Health Authority:

The Dubai Health Authority (DHA) was created, in June 2007, by Law 13 issued by His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE, Ruler of Dubai, with an expanded vision to include strategic oversight for the complete health sector in Dubai and enhance private sector engagement. 

Prior to the establishment of the DHA, the Department of Health and Medical Services, which was established in 1973, was the functioning authority that almost exclusively focused on health service delivery.

In May 2018, H.H Sheikh Mohammed, issued Law No. (6) of 2018 of the DHA. The new Law further enables the DHA to achieve its objectives including regulating medical services in Dubai, enhancing competiveness and transparency, improving medical services and products based on international best practices and achieving the sector’s objectives according to approved strategic plans.

H.H Sheikh Mohammed also issued Decree No. 17 of 2018 establishing subsidiaries of the DHA: the Dubai Healthcare Corporation and Dubai Health Insurance Corporation to further enhance healthcare services in Dubai and enable DHA to fulfil its responsibilities and obligations.

Three new strategic sectors were also added as part of the decree; they include Strategy and Corporate Development, Health Regulation, and Shared Support Services.

In addition to overseeing the health sector for the Emirate of Dubai, the DHA also focuses on providing services through DHA healthcare facilities including Latifa, Dubai, Rashid and Hatta Hospitals, its 12 primary healthcare centres, 17 medical fitness centres and its 6 specialty centres.

For more information, visit DHA’s website: www.dha.gov.ae 

© Press Release 2020

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.